Pharmaceutical: Ingredientpharm provides innovative drug carriers by changing the physical properties of existing excipients.
category-pharmceutical
ingredientpharm
ingredientpharm
ingredientpharm
ingredientpharm
ingredientpharm
ingredientpharm
GlattOnline seminar recording: Functional Tartaric Acid Pellets in Modern Formulation Challenges
Apr 05, 2022. Register for the online seminar recordings: “Functional Tartaric Acid Pellets in Modern Formulation Challenges”.
Speakers: Philippe Tschopp, Raja Subburayalu, with kind session chair by Marco Resciniti.
Sponsoring companies: Glatt Group, ingredientpharm, PHARMATRANS SANAQ AG, HARKE GROUP.
Target group: for Manager working in Pharmaceutical Technology and Formulation Sciences.
Register here: Webinar-Registrierung – Zoom
Abstract: Functional Tartaric Acid Pellets in Modern Formulation Challenges
Multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption. Present generic formulations focus on these so-called BSC Class IV drugs. The Role of Reverse Engineering is thereby an efficient key tool in the development of generic formulations. A Case study presents latest state-of-the-art achievements.
Expert presenters
The live webcast will bring interesting case provided by Pharmatrans SANAQ® and technically discussed and presented by Philippe Tschopp, Business Development at Glatt Pharmaceutical Services in Germany and Dr. Raja Subburayalu, consultant in Manufacturing Science and Technology Transfer for Zydus Cadila Healthcare Limited, based in Ahmedabad, Gujarat, India.
Reverse Engineering
Dr Subburayalu will explore how present generic formulations focus on so-called BSC Class IV drugs in which multi particulate modified release dosage forms, where the drug shows pH dependent solubility, require an acidic in-situ microenvironment to improve solubility, release, and absorption.
They will highlight how Reverse Engineering using TAP® can form an efficient key tool in the development of generic formulations. The webinar will feature a case study illustrating latest state-of-the-art achievements.
Register here for the online seminar recording
ingredientpharmStarter pellets for generic drugs, BSC Class IV
ingredientpharm extends Tartaric Acid Pellets (TAP®) portfolio adjusting to future generic drug formulations on BCS Class IV drugs. TAP are starter pellets for generic drugs, BSC Class IV.
BSC Class IV drugs have low solubility and low permeability properties. Typical drugs are Verapamil HCL, Propiverine HCL, Papaverine, Dipyridamole, or Dabigatran. Functional TAP® starter pellets increase the local solubility of these drugs.
Extending the diversity of TAP® starter pellets, ingredientpharm is now offering standard sizes and special sizes between 100 µm and 1000 µm.
See: TAP – 100% Tartaric Acid Pellets
Starter pellets for generic drugs